Stem cells injected into brain of Alzheimer’s patients in world first
Key Points:
- A pioneering Alzheimer’s treatment involving stem cells injected directly into the brain showed promising early results in a small phase one trial, with five of six patients demonstrating cognitive improvements and reductions in amyloid plaques and other biomarkers.
- The stem cells, harvested from patients' own fat tissue, were delivered through a surgically implanted reservoir, allowing repeated injections without further brain surgery.
- Although no adverse effects were reported, the trial lacked a placebo group, and the cognitive benefits observed were not sustained over a full year, highlighting the need for larger, controlled studies.
- The US FDA has granted fast-track designation to the treatment, and a phase two trial is underway to test repeated injections over a year to assess longer-term efficacy and safety.
- Experts view the approach as an exciting development that targets multiple disease mechanisms beyond amyloid clearance, but caution that more research is required to confirm its potential as a meaningful therapy for Alzheimer’s patients.